Percutaneous Microwave Ablation of Hepatocellular Carcinoma As Bridge-to-Transplant Therapy in a High-Risk Patient With Alpha-1 Antitrypsin Deficiency and Factor V Leiden Mutation: A Case Report.

Khan Z, Jafri M, Lambroussis CG, Khan Z, Khan M

Open source

DOI
10.7759/cureus.104574
Published
2026 Mar
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.104574,
  title = {Percutaneous Microwave Ablation of Hepatocellular Carcinoma As Bridge-to-Transplant Therapy in a High-Risk Patient With Alpha-1 Antitrypsin Deficiency and Factor V Leiden Mutation: A Case Report.},
  author = {Khan Z and Jafri M and Lambroussis CG and Khan Z and Khan M},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.104574},
  url = {https://doi.org/10.7759/cureus.104574}
}

RIS

TY  - JOUR
TI  - Percutaneous Microwave Ablation of Hepatocellular Carcinoma As Bridge-to-Transplant Therapy in a High-Risk Patient With Alpha-1 Antitrypsin Deficiency and Factor V Leiden Mutation: A Case Report.
AU  - Khan Z
AU  - Jafri M
AU  - Lambroussis CG
AU  - Khan Z
AU  - Khan M
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.104574
UR  - https://doi.org/10.7759/cureus.104574
ER  - 

APA

Z, K., M, J., CG, L., Z, K., & M, K. (2026). Percutaneous Microwave Ablation of Hepatocellular Carcinoma As Bridge-to-Transplant Therapy in a High-Risk Patient With Alpha-1 Antitrypsin Deficiency and Factor V Leiden Mutation: A Case Report.. Cureus. https://doi.org/10.7759/cureus.104574

Source records